RoosterBio participated in the annual Tissue Engineering and Regenerative Medicine International Society’s Annual Meeting of the Americas chapter (or TERMIS-AM for short) in Dec 2014. You can find a lot of content on the meeting at the conference website where you can download the program for free, as well as read the published abstracts in the journal Tissue Engineering. The final registration numbers for the 2014 TERMIS-AM conference in DC was 842 (about a 7% increase over last year’s conference). There were 30 countries represented at the conference, with a total of 202 oral presentations and 338 poster presentations (Stats from Sarah Wilburn at the TERMIS head office). We are looking forward to the 2015 TERMIS World Congress, which will be in Boston in early September, 2015.
There were two striking trends that were gleaned from the conference that I wanted to outline over a couple of blog posts. First, there was a noticeable rise in the number (and quality) of the Biofabrication-related talks and posters (this blog post will focus on this). The second trend to note was the rise in Product Development content at the 2014 meeting – and this will be the focus of a subsequent blog post. Interestingly, the intersection of these two topics (manufacturing process technologies and product development) has traditionally been crucial for the successful commercialization of high tech products, including biopharmaceuticals (see recent HBR article by Pisano and Shih here).
|Our favorite booth (after the RoosterBio booth, or course) was BioBots', who were |
showing off the beta version of the BioBot Rapid 3D Bio-Prototyper.
The Rise of BioFabrication and BioPrinting in Tissue Engineering
TERMIS has always been a great conference for academic Tissue Engineering technologies. The major comment that I always heard from fellow industrialists was just how “academically” focused the conference was. Meaning that the